Kazuyoshi Ishii, MD^1*, Masahiro Manabe, MD^2*, Toshiya Yagi, MD^2*, Hirofumi Teshima, MD^2*, Yasuaki Nagare, MD^3*, Hidetsugu Kimura, MD^3*, Fumiaki Urase, MD^3*, Kunio Hayashi, MD⁴, Masaru Shibano, MD^5*, Machiko Tsukaguchi, MD^5*, Tatsuya Katsurada, MD^6*, Atsuko Mugitani, MD^7*, Hitoshi Kitayama, MD^8* and Shosaku Nomura, MD^1*

¹Hematology, Kishiwada City Hospital, Kishiwada, Japan
²Hematology, Osaka City General Hospital, Osaka, Japan
³Internal Medicine, Sakai Hospital, Kinki University School of Medicine, Sakai, Japan
⁴Hematology, Hirakata Kosai Hospital, Hirakata, Japan
⁵Hematology, Sakai Municipal Hospital, Sakai, Japan
⁶Hematology, Takeda General Hospital, Kyoto, Japan
⁷Hematology, Fuchu Hospital, Izumi, Japan
⁸Internal Medicine, Hoshigaoka Kosei Nenkin Hospital, Hirakata, Japan

Cathrin C Skrabs^1*, Alexander Hauswirth^1*, Karin Eigenberger^1*, Christine Einberger^1*, Markus Raderer^2*, Wolfgang R Sperr^1*, Paul Knoebl^1*, Leonhard Muellauer^3*, Martin Uffmann^4*, Karin Dieckmann^5*, Alexander Gaiger^1* and Ulrich Jaeger, MD¹

¹Dept. of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
²Dept. of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria
³Department of Pathology, Medical University of Vienna, Vienna, Austria
⁴Department of Radiology, Medical University of Vienna, Vienna, Austria
⁵Department of Radiotherapy, Medical University of Vienna, Vienna, Austria

Fernando Cabanillas, MD¹, Jorge Toro^2*, Jorge Perdomo^3*, Orestes Pavia^1*, Idalia Liboy^1*, Clara Salgado^1*, Viviana Freire^1*, Ezequiel Rivera^1* and Norman Maldonado^4*

¹Hospital Auxilio Mutuo, Cancer Center, San Juan, PR
²Sononuclear, San Juan, PR
³Hato Rey Hematology Oncology Group, San Juan, PR
⁴Hospital del Maestro, San Juan, PR

Birgit Burkhardt, MD, PhD^1*, Alfred Reiter, MD², Eva Landmann, MD^2*, Peter J. Lang, MD³, Lisa Lassay, MD^4*, Roswitha Dickerhoff, MD⁵, Max Lakomek, MD^6*, Guenter Henze, MD^7* and Arend von Stackelberg, MD^7*

¹Department of Pediatrics, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
²Dept. of Pediatric Hematology and Oncology, Children's University Hospital, Giessen, Germany
³Dept. of Hematology/Oncology, Children's University Hospital, Tubingen, Germany
⁴Dept. Pediatric Hematology/Oncology, Children's University Hospital, Aachen, Germany
⁵Children's Hospital, Saint Augustin, Germany
⁶Dept. Pediatric Hematology/Oncology, Children's University Hospital, Goettingen, Germany
⁷Ped. Oncology/Hematology, Charité, Med. Univ., Berlin, Berlin, Germany

Kieron Dunleavy, MD, Stefania Pittaluga, MD, PhD^*, Nicole Grant, MPH^*, Seth Steinberg, PhD^*, Margaret Shovlin, RN^*, Kevin Tay, MD^*, John E. Janik, MD^*, Elaine S. Jaffe, M.D.^* and Wyndham H. Wilson, MD, PhD

Center for Cancer Research, National Cancer Institute, Bethesda, MD

Jacoline E.C. Bromberg^1*, Jeanette Doorduyn², Macha Schuurmans^1*, Philip Poortmans^3*, Martin J.B. Taphoorn^4*, Tatjana Seute^5*, Adriaan W. Dekker, MD⁶, Roelien H. Enting^7*, Gustaaf van Imhoff⁸, Yvette van Norden^9* and Martin van den Bent^1*

¹Neuro-Oncology, ErasmusMC, Daniel den Hoed Cancer center, Rotterdam, Netherlands
²Hematology, ErasmusMC, Daniel den Hoed Cancer center, Rotterdam, Netherlands
³Radiotherapy, Dr. Bernard Verbeeten Institute, Tilburg, Netherlands
⁴Neurology, Medisch Centrum Haaglanden, Den Haag, Netherlands
⁵Neurology, University Medical Center Utrecht, Utrecht, Netherlands
⁶University Hospital Ultrecht, B02.226, Utrecht, Netherlands
⁷Neuro-Oncology, University Medical Center Groningen, Groningen, Netherlands
⁸Hematology, Groningen University Medical Center, Groningen, Netherlands
⁹Trials and Statistics, ErasmusMC, Daniel den Hoed Cancer center, Rotterdam, Netherlands

Stefan W Krause, MD^1*, Reinhard Andreesen², Ferdinand Hofstädter^3* and Michael Gerken^4*

¹Medizinische Klinik 5, Universitätsklinikum, Erlangen, Germany
²Haematologie/Onkologie, Universitaetsklinik Regensburg, Regensburg, Germany
³Institut für Pathologie, Universitaet Regensburg, Regensburg, Germany
⁴Tumorzentrum Regensburg, Regensburg, Germany

Rita Mazza, MD^1*, Monica Demarco, MD^1*, Michele Spina, MD², Massimo Magagnoli, MD^1*, Luca Castagna, MD^1*, Licia Siracusano, MD^1*, Laura Giordano, PhD^1*, Umberto Tirelli, MD^2*, Armando Santoro, MD^1* and Monica Balzarotti, MD^1*

¹Oncology - Hematology, Istituto Clinico Humanitas, Rozzano, Italy
²Medical Oncology, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy

Gerald Illerhaus^1*, Fabian Müller^2*, Friedrich Feuerhake^3* and J.ürgen Finke⁴

¹hematology / Oncology, University Hospital Freiburg, Medical Center, Freiburg, Germany
²Hematology / Oncology, University Hospital Freiburg, Medical Center, Freiburg, Germany
³Dept. of Neuropathology, University Hospital Freiburg, Medical Center, Freiburg, Germany
⁴Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany

Jeremy S. Abramson, MD¹, Jeffrey A. Barnes, M.D.^1*, Christiana E. Toomey^1*, Eric D. Jacobsen, MD², Philippe Armand^2*, Tak Takvorian, MD^1*, David C. Fisher, MD², Hazel Reynolds^2*, Ephraim P. Hochberg¹ and Ann S. LaCasce, MD²

¹Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
²Dana-Farber Cancer Inst., Boston, MA

Kirsten Herbert, MBBS, FRACP, PhD¹, Max Wolf, MBBS, FRACP, FRCPA², Dennis Carney, MBBS, FRACP, FRCPA^2*, David Alan Westerman, MBBS, FRACP, FRCPA^3*, Henry Januszewicz, MBBS, FRACP, FRCPA^3*, Simon Harrison, MBBS, PhD^3*, David Ritchie, MBChB, FRACP, FRCPA, PhD^3*, H. Miles Prince³ and John Francis Seymour, MBBS, FRACP, PhD⁴

¹Dept. of Hematology, Peter MacCallum Cancer Center, East Melbourne, Australia
²Dept. of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
³Dept. of Haematology and Medical Oncology, Peter MacCallum Cancer Center, East Melbourne, Australia
⁴Dept. of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia

Peter J Hosein, MD, Daniel Morgensztern, MD^*, Francine Coleman, MPH^*, Gail Walker, PhD^*, Maricer Escalon, MD, Joseph Rosenblatt, MD and Izidore S Lossos, MD

University of Miami Miller School of Medicine, Miami, FL

Thomas P. Miller, MD¹, Joseph M Unger, MS^2*, Catherine Spier, MD^1*, Baldassarre Stea, MD, PhD^1*, Oliver W. Press, MD, PhD², Jonathan W. Friedberg, MD³, Michael LeBlanc, PhD^2* and Richard I Fisher, MD^4*

¹Arizona Cancer Center, Tucson, AZ
²Fred Hutchinson Cancer Research Center, Seattle, WA
³James P. Wilmot Cancer Center, University of Rochester, Rochester, NY
⁴Wilmot Cancer Center, Rochester, NY

Hisashi Tsurumi, MD, PhD¹, Naoe Goto^2*, Takeshi Hara¹, Senji Kasahara¹, Nobuhiro Kanemura¹, Junichi Kitagawa, MD^1*, Takeshi Yoshikawa^3*, Toshiki Yamada^1*, Michio Sawada^1*, Takeshi Takahashi^3*, Tsuyoshi Takami^2* and Hisataka Moriwaki^1*

¹First Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
²Department of Immunopathology, Gifu University Graduate School of Medicine, Gifu, Japan
³Division of Hematology, Gifu Municipal Hospital, Gifu, Japan

Ingo Schmidt-Wolf¹, Hendrik Pels^2*, Annika Jürgens^2*, Sabine Rogowski^2*, Axel Glasmacher, MD³, Ulrich Herrlinger^1*, Holger Schulz^4*, Andreas Engert, MD⁵, Michael Linnebank^6*, Gabriele Schackert^1*, Heinz Reichmann^7*, Frank Kroschinsky^7*, Marlies Vogt-Schaden^1*, Gertlinde Egerer^8*, Carlo Schaller^9*, Monika Lamprecht^1*, Peter Hau^1*, Martina Deckert^4*, Rolf Fimmers^1*, Christoph Bangard^4* and Uwe Schlegel^2*

¹CIO, Med. Klinik und Poliklinik III, University of Bonn, Bonn, Germany
²University of Bochum, Bochum, Germany
³Celgene GmbH, Muenchen, Germany
⁴CIO, Med. Klinik, University of Cologne, Cologne, Germany
⁵Cochrane Haematological Malignancies Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
⁶Klinik und Poliklinik für Neurologie, University of Bonn, Bonn, Germany
⁷University of Dresden, Dresden, Germany
⁸University of Heidelberg, Heidelberg, Germany
⁹University of Cologne, Department I Internal Medicine, Cologne

Myung Hee Chang^1*, Seok Jin Kim, MD, PhD¹, Won Seog Kim^1*, Chul Won Choi, MD, PhD^2*, Cheolwon Suh³, Sung Hyun Kim, MD, PhD⁴, Deok-Hwan Yang^5*, Jong-Ho Won⁶ and Soon Il Lee^7*

¹Medicine, Samsung Med. Ctr., Seoul, South Korea
²Internal Medicine, Korea University Guro Hospital, Seoul, South Korea
³Asan Medical Center, Seoul
⁴Dept. of Hem.-Onc., Internal Med., Dong-A University Hospital, Pusan, South Korea
⁵Hematology-Oncolology, Chonnam National University Hwasun Hospital, Jeollanam-do, South Korea
⁶Soon Chun Hyang University Hospital, Seoul
⁷Internal Medicine,, Dankook University College of Medicine, Cheonan, South Korea

Ingo Schmidt-Wolf¹, Hendrik Pels^2*, Annika Jürgens^2*, Katrin Patrij^1*, Luise Wätzel^3*, Ulrich Herrlinger^4*, Holger Schulz^3*, Andreas Engert, MD⁵, Michael Linnebank^4*, Gabriele Schackert^6*, Heinz Reichmann^7*, Frank Kroschinsky^8*, Marlies Vogt-Schaden^9*, Gertlinde Egerer^9*, Carlo Schaller^10*, Monika Lamprecht^11*, Peter Hau^12*, Martina Deckert^13*, Rolf Fimmers^14*, Christoph Bangard^3* and Marcel Reiser^15*

¹CIO, Med. Klinik und Poliklinik III, University of Bonn, Bonn, Germany
²University of Bochum, Bochum, Germany
³CIO, Med. Klinik, University of Cologne, Cologne, Germany
⁴Klinik und Poliklinik für Neurologie, University of Bonn, Bonn, Germany
⁵Cochrane Haematological Malignancies Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
⁶Neurologische Klinik, University of Dresden, Dresden, Germany
⁷University of Dresden, Dresden, Germany
⁸Medizinische Klinik, University of Dresden, Dresden, Germany
⁹University of Heidelberg, Heidelberg, Germany
¹⁰University of Cologne, Department I Internal Medicine, Cologne
¹¹University of Kiel, Kiel, Germany
¹²University of Regensburg, Regensburg, Germany
¹³University of Cologne, Cologne, Germany
¹⁴University of Bonn, Bonn, Germany
¹⁵Klinikum, Universität zu Köln, Köln, Germany

Alessandro Re^1*, Alessandra Tucci^1*, Salvatore Casari^2*, Chiara Cattaneo^1*, Graziella Cristini^3*, Giampiero Carosi^2* and Giuseppe Rossi¹

¹Department of Hematology, Spedali Civili, Brescia, Italy
²Department of Infectious Diseases, Univerity of Brescia, Brescia, Italy
³Infectious Diseases, Spedali Civili, Brescia, Italy

Harald Holte, MD, PhD^1*, Sirpa M. Leppa, MD, PhD², Magnus Bjorkholm, MD, PhD³, Oystein Fluge, MD, PhD^4*, Sirkku Jyrkkio, MD, PhD^5*, Jan Delabie, MD, PhD^6*, Christer Sundstrom, MD, PhD^7*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD^8*, Martin Erlanson, MD, PhD^9*, Arne Kolstad, MD, PhD^1*, Alexander Fossa, MD, PhD^1*, Björn Östenstad, MD, PhD^10*, Eva Lofvenberg, MD, PhD¹¹, Marie Nordström, MD, PhD^11*, Lars Möller-Pedersen, MD, PhD^12*, Harald Anderson, PhD^13*, Mats Jerkeman, MD, PhD^14* and Mikael Eriksson, MD, PhD^14*

¹Oncology, Norwegian Radium Hospital, Oslo, Norway
²Oncology, Helsinki University Central Hosp., Helsinki, Finland
³Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
⁴Oncology and Radiotherapy, Haukeland University Hospital, Bergen, Norway
⁵Oncology and Radiotherapy, Turku University Centre Hospital, Turku, Finland
⁶Pathology, Norwegian Radium Hospital, Oslo, Norway
⁷Pathology, Academic Hospital, Uppsala, Sweden
⁸Pathology, Helsinki University Central Hosp., Helsinki, Finland
⁹Oncology, Norrlands University Hospital, Umeå, Sweden
¹⁰Oncology, Ulleval University Hospital, Oslo, Norway
¹¹Hematology, Karolinska University Hospital, Stockholm, Sweden
¹²Hematology, Odense University Hospital, Odense, Denmark
¹³Cancer Epidemiology, Lund University, Lund, Sweden
¹⁴Oncology, Lund University Hospital, Lund, Sweden

Tsuneaki Hirakawa^1*, Hiroki Yamaguchi¹, Seiji Gomi^2*, Norio Yokose^3*, Koiti Inokuchi¹ and Kazuo Dan¹

¹Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
²Department of Hematology, Yokohama Minami Kyosai Hospital, Kanagawa, Japan
³Department of Internal Medicine, Chiba Hokusoh Hospital, Nippon Medical School, Chiba, Japan

Kieron Dunleavy, MD, Richard Little, MD^*, Alan S. Wayne, MD^*, Nicole Grant, MPH^*, Stefania Pittaluga, MD, PhD^*, Elaine S. Jaffe, MD^*, Seth Steinberg, PhD^*, Robert Yarchoan, MD, PhD^*, Jorge A. Carrasquillo, MD^*, John E. Janik, MD^* and Wyndham H. Wilson, MD, PhD

Center for Cancer Research, National Cancer Institute, Bethesda, MD

Federica Gigli^1*, Luca Nassi^1*, Mara Negri^1*, Laura Travaini^2*, Sara Steffanoni^1*, Sarah Jane Liptrott^1*, Patrizia Mancuso^1*, Paola Bertazzoni^1*, Simona Bassi, MD^1*, Liliana Calabrese^1*, Emilia Cocorocchio^1* and Giovanni Martinelli¹

¹Hematology, European Institute of Oncology, Milan, Italy
²Nuclear Medicine, European Institute of Oncology, Milan, Italy

Sergio Cortelazzo, MD^1*, Michael Mian, MD^1*, Maria Cantonetti, MD^2*, Andreas Sarris, MD^3*, Andrea Rossi, MD^4*, Alessandro Rambaldi, MD⁴, Giuseppe Lombardo, MD^5*, Felice Pasini, MD^6*, Achille Ambrosetti, MD^7*, Liliana Devizzi, MD^8*, Mario Busetto, MD^9*, Osnat Bairey, MD^10*, Emilio Berti, MD^11*, Giovanni Martinelli, MD¹², Richard Tsang, MD^13*, Silvia Rudoy, MD^14*, Robert Blum, MD^15*, Andres JM Ferreri, MD¹⁶, Graziella Pinotti, MD^17*, Enrico Pogliani, MD^18* and Emanuele Zucca, MD^19*

¹Div. of Hematology and BMT, Bolzano, Italy
²Chair of Hematology, University of Rome
³Hematology, Hygeia
⁴Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy
⁵Istituto Dermatologico Italiano
⁶Chair of Oncology, University of Verona
⁷Chair of Hematology, University of Verona
⁸Istituto Nazionale Tumori, Milano, Italy
⁹Radiotherapy, Venice
¹⁰Institute of Hematology, Rabin Medical Center
¹¹Dermatologia, University of Milan-Bicocca and Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
¹²Hematology, European Institute of Oncology, Milan, Italy
¹³Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
¹⁴Hematology, Instituto Santojiani, Buenos Aires, Argentina
¹⁵Haematology, Melbourne, Australia
¹⁶Unit of Lymphoid Malignancies, Department of Oncology, Istituto Scientifico San Raffaele, Milano, Italy
¹⁷UO Oncologia Medica, Ospedale di Circolo Fondazione Macchi, Varese
¹⁸Chair of Hematology, University of Milan-Bicocca
¹⁹Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

Igor Aurer^1*, Houchingue Eghbali², John M. Raemaekers³, Hussein M Khaled^4*, Martine Van Glabbeke^5*, Liliana Baila^5* and Richard van der Maazen^6*

¹Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
²Institut Bergonie, Bordeaux, France
³Dept. of Hematology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
⁴National Cancer Institute, Cairo, Egypt
⁵EORTC Data Center, Brussels, Belgium
⁶Dept. of Radiation Oncology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

Minnie Abromowitch, MD¹, Amanda Termuhlen, MD^2*, Myron Chang, PhD^3*, Sherrie L. Perkins, MD, PhD⁴, Thomas Gross, MD, PhD⁵, Howard J. Weinstein, MD⁶ and Jonathan Finlay, MD^7*

¹Pediatric Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
²Dept of Pediatric Hem-Oncology, Nationwide Childrens Hospital, Columbus, OH
³Data Center, Childrens Oncology Group, Gainesville, FL
⁴Pathology, University of Utah and ARUP Institute, Salt Lake City, UT
⁵Nationwide Children's Hospital, The Ohio State University, Columbus, OH
⁶Mass General Hosp. for Children, Boston, MA
⁷Peds Hematology/Oncology, Childrens Hospital Los Angeles, Los Angeles, CA

Laura Moise, M.D.^1*, Clemence Matta^1*, Sylvain Pilorge^1*, Marius Moldovan^1*, Christophe Ferme, MD^2*, Antoine Durrbach^3* and Vincent Ribrag, MD⁴

¹Medicine, Institut Gustave Roussy, Villejuif, France
²Dept. of Medicine, Institut Gustave Roussy, Villejuif, France
³Nephrology, CHU paris XI, Le Kremlin-Bicetre, France
⁴Dpt. of Medicine, Institut Gustave Roussy, Villejuif, France

Silvia Montoto, MD¹, Jamie Wilson^2*, Kate Shaw^3*, Maureen Heath^4*, Andy Wilson^1*, Chloe Orkin^5*, Christopher McNamara^2*, Margaret Johnson^6*, Mark Bower^3* and Kate Cwynarski^2*

¹CR-UK Medical Oncology Unit, St Bartholomew's Hospital, Barts and The London School of Medicine and Dentistry, London, United Kingdom
²Haematology, Royal Free Hospital, London, United Kingdom
³Medical Oncology, Chelsea & Westminster Hospital, London, United Kingdom
⁴Medical Oncology, St Bartholomew's Hospital, London, United Kingdom
⁵Infection and Immunity, St Bartholomew's Hospital, London, United Kingdom
⁶HIV Medicine, Royal Free Hospital, London, United Kingdom

Ulrike Appel^1*, Carl Hinrichs^2*, Petra Reinke^2*, Nina Babel^2*, Hans H Neumayer^3*, Klemens Budde^3*, Martin Dreyling⁴, Ulrich Dührsen^5*, Volker Kliem^6*, Silke Schüttrumpf^7*, Ingeborg A Hauser^8*, Hans G Mergenthaler^9*, Bernd Dörken¹⁰, Ioannis Anagnostopoulos^11*, Hanno Riess^1* and Ralf Trappe^1*

¹Department of Hematology and Oncology, Campus Virchow Clinic, Charité - Universitätsmedizin Berlin, Berlin, Germany
²Department of Nephrology and Intesive Care, Campus Virchow Clinic, Charité-Universitätsmedizin Berlin, Berlin, Germany
³Department of Nephrology, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany
⁴Department of Internal Medicine III, University Hospital Grosshadern, University of Munich, Munich, Germany
⁵Clinic of Hematology, University Hospital, University of Duisburg-Essen, Essen, Germany
⁶Department of Internal Medicine/Nephrology, Nephrological Center, Hann. Muenden, Hann. Muenden, Germany
⁷Department of Hematology/Oncology, University of Göttingen, Göttingen, Germany
⁸Medical Clinic III, Clinic of the J.W. Goethe University, Frankfurt/Main, Germany
⁹Department of Hematology and Oncology, Section Internal Medicine, Klinikum Stuttgart - Katharinenhospital and Bürgerhospital, Stuttgart, Germany
¹⁰Department of Hematology and Oncology, Campus Virchow Clinic, Charité - Universitätsmedizin Berlin, Berlin, Germany
¹¹Department of Pathology, Campus Benjamin Franklin, Charité - Universitätsmedizin, Berlin, Germany

Sylvain Choquet^1*, Stefan Oertel^2*, Ioannis Anagnostopoulos^3*, Hanno Riess^4*, Madalina Uzunov^5*, V.éronique Leblond^6* and Ralf Trappe^7*

¹Clinical Haematology, hôpital Pitié Salpêtrière, APHP, Paris, France
²Roche, Basel
³Department of Pathology, Campus Benjamin Franklin, Charité - Universitätsmedizin, Berlin, Germany
⁴Clinical Haematology, hôpital Pitié Salpêtrière, APHP, Berlin, Germany
⁵Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Paris, France
⁶Hopital Pitie-Salpetriere, Paris, France
⁷Medizinische Klinik m.S. Hämatologie & Oncologie, Campus Virchow, Charité, Berlin, Germany

Gonzalo Gutiérrez-García^1*, Luis Colomo^2*, Neus Villamor^1*, Leonor Arenillas^1*, Antonio Martínez^2*, Mireia Camós^1*, Marina Diaz-Beyá^1*, Carlos Fernández de Larrea^1*, Xavier Calvo^1*, Eva Giné^1*, Francesc Bosch^1*, Elias Campo^2*, Emili Montserrat¹ and Armando López-Guillermo¹

¹Hematology, Hospital Clinic, Barcelona, Spain
²Pathology, Hospital Clinic, Barcelona, Spain

Yasushi Takamatsu, MD, PhD^1*, Junji Suzumiya, MD², Atae Utsunomiya, MD^3*, Koichi Maeda, MD^4*, Hitoshi Matsuoka, MD^5*, Hitoshi Suzushima, MD^6*, Junichi Tsukada, MD, PhD⁷ and Kazuo Tamura, MD, PhD^8*

¹Division of Medical Oncology, Hematology, and Infectious Disease, Fukuoka University Hospital, Fukuoka, Japan
²2nd Dept. of Internal Med., Fukuoka Univ. Chikushi Hosp., Chikushino, Japan
³Dept. of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
⁴Department of Hematology, Miyakonojo National Hospital, Miyakonojo, Japan
⁵Department of Hematology, Koga General Hospital, Miyazaki, Japan
⁶Department of Hematology, NTT West Kyushu General Hospital, Kumamoto, Japan
⁷Cancer Chemotherapy Ctr., University of Occupational, Kitakyushu, Japan
⁸Division of Medical Oncology, Hematology, and Infectious Disease, Fukuoka University, Fukuoka, Japan